Clinical trial recruitment challenges rarely begin when enrolment starts. More often, they originate much earlier, during country selection and site evaluation. As sponsors expand into new geographies to access patients, increase diversity, and meet increasingly complex protocol requirements, many discover that patient availability alone does not guarantee recruitment success. The real determinant of performance is whether sites are ready to identify, engage, and enrol patients effectively in the real world.

This guide outlines how Site Enrollment & Engagement Leads work to assist IQVIA’s core study Operational Groups [Clinical Operations and Site Activation teams] reduce uncertainty, improve site readiness, and create a more predictable path to recruitment performance.

Why Recruitment Performance Often Falls Short

Sponsors frequently select countries based on epidemiology, patient availability, and high-level feasibility indicators. However, these measures do not always reveal the realities of local healthcare systems, referral networks, site capabilities, or operational barriers. During a recent webinar, IQVIA experts highlighted that hidden risks such as investigator capacity, site maturity, staffing constraints, referral patterns, and local patient pathways often emerge only after activation, when timelines and budgets are already under pressure.

For Clinical Operations leaders, this creates a common challenge:

How can sponsors assess whether a site can actually recruit and perform before activation?

This is where Site Enrollment & Engagement Leads provide value.

What Are Site Enrollment & Engagement Leads?

Site Enrollment & Engagement Leads are field-based healthcare professionals who operate as an fully dedicated field based extension of the sponsor or CRO. Their primary role is to accelerate site understanding, identify recruitment barriers, and build operational confidence in recruitment delivery before and during study execution.

Unlike site-based resources, they focus on enrolment strategy, site engagement, referral pathways, community outreach, recruitment planning and support, site education, and patient retention support.

Their objective is simple:

Turn assumptions about recruitment potential into evidence-based understanding.

Four Ways Site Enrollment and Engagement Leads Improve Recruitment Performance

1. Mapping Real Patient Pathways

One of the most common reasons recruitment forecasts fail is that sponsors do not fully understand how patients move through local healthcare systems.

Site Enrollment and Engagement Leads investigate where patients are diagnosed, where they receive treatment, how referrals occur, and how public and private care systems interact. This helps sponsors understand actual patient flow rather than relying solely on epidemiological estimates. The webinar emphasized that recruitment success depends on how patients move through healthcare systems, not simply how many patients exist within a country.

Recruitment benefit: More accurate patient identification strategies and stronger site selection decisions.

2. Identifying the Right Sites and Investigators

Not every high-performing site appears on traditional feasibility lists.

SEELs conduct site ecosystem assessments to evaluate investigator interest, operational capacity, referral networks, competitive pressures, and site readiness. This process helps uncover high-potential sites and emerging investigators that may otherwise be overlooked. During the webinar, a rare disease case study demonstrated how SEEL-led field intelligence identified an investigator and site in Latvia that ultimately became one of the highest recruiting and highest quality sites in the study.

Recruitment benefit: Better site prioritization and access to previously hidden recruitment opportunities.

3. Surfacing Hidden Operational Barriers Before Activation

Traditional feasibility often captures what sites report formally, but not how they operate day to day.

SEELs help identify operational challenges such as diagnostic bottlenecks, scheduling constraints, staffing gaps, approval hurdles, referral delays, logistical limitations, and technology challenges. The webinar highlighted that these issues can significantly affect activation, screening, and enrolment performance if left undiscovered until trial execution begins.

By identifying these barriers early, sponsors can determine whether a site requires additional support, process adjustments, or alternative planning before timelines are affected.

Recruitment benefit: Reduced risk of activation delays and fewer surprises during enrolment.

4. Creating a More Predictable Recruitment Strategy

The most successful recruitment programmes combine site intelligence with operational planning.

SEELs provide local insight that helps sponsors understand which countries and sites are likely to succeed, where risks exist, and what interventions may be needed to improve performance. This transforms early assumptions into practical recruitment strategies grounded in real-world site conditions. The ultimate goal is to move from uncertainty to operational confidence before activation begins.

Recruitment benefit: More realistic enrolment forecasts and greater delivery predictability.

Best Practices for Clinical Operations Leaders

Sponsors looking to strengthen recruitment performance in new geographies should consider the following approach:

Build Insight Early

Engage local expertise before feasibility is fully mature. Early intelligence helps identify risks before country and site decisions are finalized.

Validate Readiness, Not Just Patient Numbers

Assess site capability, infrastructure, workflows, investigator engagement, and operational maturity alongside patient availability.

Understand Local Recruitment Dynamics

Map referral pathways, treatment journeys, standard of care, and healthcare delivery models to understand how patients enter studies in practice.

Use Findings to Inform Site Support

Once barriers are identified, targeted interventions can be deployed to address recruitment and execution challenges before they impact performance.

The Bottom Line

As global clinical development expands into increasingly complex and unfamiliar markets, recruitment performance depends on far more than patient access. Sponsors need a deeper understanding of site ecosystems, operational readiness, investigator capability, and local patient pathways before activation begins.

Site Enrollment & Engagement Leads help bridge this gap by generating country intelligence, validating site readiness, uncovering hidden recruitment barriers, and helping sponsors make more informed decisions. By turning uncertainty into actionable insight, SEELs help Clinical Operations leaders improve recruitment performance, reduce execution risk, and create a more predictable path from country selection to successful study delivery.